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Summary Polymorphisms of the haptoglobin (HP) gene and deletions in -globin gene (-
thalassaemia) are common in malaria-endemic Africa. The same region also has high incidence




idiopathic generalized epilepsies and altered iron metabolism in children with -thalassaemia
can potentially interfere with neurotransmission and increase the risk of seizures. We investi-
gated the hypothesis that the HP2-2 genotype and the common African -globin gene deletions
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Polymorphisms and acute seizures in children 115
are associated with the increased risk of seizures. 288 children aged 3—156 months admitted with
acute seizures to Kiliﬁ District Hospital (Kenya), were matched for ethnicity to an equal number
of community controls. The proportion of cases (72/288 [25.0%]) and controls (80/288 [27.8%])
with HP2-2 genotype was similar, p = 0.499. The allele frequency of HP2 gene in cases (49.3%) and
controls (48.6%) was also similar, p = 0.814. Similarly, we found no signiﬁcant difference between
the proportion of cases (177/267 [66.3%]) and controls (186/267 [69.7%]) with deletions in -
globin gene (p = 0.403). Among cases, HP2-2 polymorphism and deletions in -globin gene were
neither associated with changes in the type, number or duration of seizures nor did they affect






































ticipate in the study and consent obtained. The history included
the number, duration, and a description of the seizures and a his-
tory of previous seizures in the child. Level of consciousness wasfactors for acute seizures in
Introduction
Seizures are a common neurological symptom in sick chil-
dren admitted to hospital. In parts of malaria-endemic
Africa, over 15% of paediatric admissions may have a his-
tory of seizures (Obi et al., 1994; Berkley et al., 2003) and
acute seizures are amajor risk factor for epilepsy later in life
(Carter et al., 2004; Ngoungou et al., 2006). Most seizures
occur in febrile children and are precipitated by infections
(Akpede et al., 1993; Obi et al., 1994; Waruiru et al., 1996)
but in some, genetic factors may be important (Obi et al.,
1994; Versteeg et al., 2003).
Polymorphisms of the haptoglobin (HP) gene and dele-
tions in the -globin gene (-thalassaemia) are very common
in malaria-endemic Africa (Williams et al., 2005; Atkinson
et al., 2007) and both the HP2-2 polymorphism and -
thalassaemia have been associated with protection against
malaria (Williams et al., 2005; Atkinson et al., 2006, 2007;
Wambua et al., 2006). The same region also has high inci-
dence rates for childhood acute seizure disorders (Berkley et
al., 2003; Idro et al., 2007). It is unclear whether these poly-
morphisms or deletions and the high incidence of seizures
are associated.
Haptoglobin is a protein that binds free haemoglobin in
circulation. The gene has three main polymorphisms: HP1-
1, HP1-2 and HP2-2. Proteins expressed by this polymorphic
gene have grossly different molecular sizes resulting into
different rates of diffusion in the brain. In addition, hap-
toglobin expressed by the HP2-2 genotype has the least
haemoglobin binding capacity and studies have associated
this genotype with idiopathic generalized epilepsy (Saccucci
et al., 2004; Sadrzadeh et al., 2004). The mean plasma hap-
toglobin level in patients with idiopathic epilepsy is also
lower than that in normal population controls (Panter et
al., 1985). It has been suggested that, a defective free
haemoglobin clearing system after central nervous sys-
tem micro-hemorrhage events in persons with the HP2-2
genotype may be involved in the development of chronic
seizure disorders (Panter et al., 1985; Sadrzadeh et al.,
2004).
The relationship between the -thalassaemias and acute
seizures has not been reported. It is postulated that, chil-
dren with thalassaemia have an increased oxidative stress on
neurons and an altered iron metabolism. The change in iron
metabolism may interfere with activities of gamma amino
butyric acid and the glutamate system (Auvichayapat et al.,
2004) and alter the risk for seizures. Only one retrospective





dren. Future studies should examine other susceptibility genes.
© 2008 Elsevier B.V.
ith -thalassaemia and the incidence was lower than that
n the general population (Auvichayapat et al., 2004).
We hypothesized that compared to children with HP1-
and HP1-2 genotypes or those without deletions in the
-globin gene, children with HP2-2 genotype or the com-
on African -globin gene deletion have an increased risk
f developing acute seizures. We recruited children hospital-
zed with acute seizures and compared their HP genotypes




he study was conducted in Kiliﬁ District on the coast of Kenya
here most residents are collectively known as the Mijikenda, a
antu grouping of nine tribes, with the Giriama (45%), Chonyi (33%),
nd Kauma (11%) forming the major groups. It was part of a bigger
pidemiological study that investigated the incidence, risk factors
nd outcome of acute seizures in children in our community pre-
enting to Kiliﬁ District hospital (Idro et al., 2008). In the catchment
rea of the hospital, a system of continuous demographic surveil-
ance (DSS) is maintained for a population of about 230,000 (Berkley
t al., 2005). Cases for the study were children from within the
SS aged 3—156 months, consecutively admitted to the pediatric
ards of the hospital with acute seizures. Children with epilepsy
two lifetime episodes of unprovoked seizures) were excluded. Con-
rols were children born in the hospital who had cord blood samples
ollected and archived, and were frequency matched to cases on
he basis of ethnicity. The primary exposure of interest was the hap-
oglobin HP2-2 genotype. We estimated that a sample size of 248
ases and 248 controls would give 90% power to detect an OR of 2.0
t 5% level of signiﬁcance given a prevalence of HP2-2 in the com-
unity of 25% (Farrer and Cupples, 1998; Atkinson et al., 2007).
thical approval for the study was granted by the Kenya Medical
esearch Institute.
rocedures
he cases received emergency care and resuscitation based on
tandard guidelines (WHO, 2000). Parents were then invited to par-
Open access under CC BY license.ssessed using the Blantyre Coma Scale (Molyneux et al., 1989).
peciﬁc anti-microbial therapy was given for malaria and for bacte-
ial infections. A child was said to have malaria if s/he had malaria
arasitaemia and clinical examination and lab tests excluded other
iagnoses. At discharge, all patients were assessed for the presence
116 R. Idro et al.
Table 1 Haptoglobin genotypes in children with acute seizures and controls
Subject group Haptoglobin genotypes Total, N Allele frequency Total, N
HP1-1, n (%) HP1-2, N (%) HP2-2, n (%) HP1, n (%) HP2, n (%)



































































gControls 88 (30.5) 120 (41.7) 80 (27.
The allele frequency of the HP2-2 genotype in cases and controls
f neurological deﬁcits and those with deﬁcits referred for follow
p care.
Venous blood was drawn and plasma from both cases and con-
rols was immediately separated by centrifugation and the cell
ellet frozen and stored at −80 ◦C. DNA was extracted using com-
ercially available kits according to the manufacturers instructions
PUREGENE® DNA extraction kit, GENTRA SYSTEMS, Boston, MA) and
aptoglobin and thalassaemia genotyping was performed by PCR
s previously described (Chong et al., 2000; Williams et al., 2005;
tkinson et al., 2006).
tatistical analysis
o investigate the association between acute seizures and these
enetic traits, we compared the prevalence of HP2-2 genotypes,
-thalassaemia deletion types and allele frequency in cases and
ontrols using Pearson’s chi-square test and the chi-square test for
inear trend. In addition, we compared the seizure types (general-
zed, focal or secondarily generalized) and the median number of
eizures in children with the different genotypes with the Wilcoxon
ank-sum Test. We also performed a sub analysis comparing the
enotypes of cases with Plasmodium falciparum infection.
esults
eneral description
hree hundred and twenty ﬁve children, consecutively
dmitted with acute seizures to Kiliﬁ District hospital,
etween December 2004 and August 2005 were recruited.
aptoglobin genotyping was successful in 294 (90.5%) of
hom, 288 were frequency matched for ethnicity to an
qual number of controls from the birth cohort (six cases
id not have matching ethnic groups in the birth cohort).
n 267 out 288 (92.7%) children, both the haptoglobin geno-
ype and -thalassaemia type was available and the cases
nd controls could be matched for ethnicity. The majority
f cases, 167 (58.0%) were from the Giriama ethnic group,
7 (23.3%) were Chonyi, 32 (11.1%) Kauma while the remain-
ng 22 cases belonged to the Digo, Duruma, Jibana, Kambe,





Table 2 -Thalassaemia genotypes and acute seizures in childre







Cases 90 (33.7) 128 (47.9) 49 (18.4)
Controls 81 (30.3) 150 (56.2) 36 (13.5)
The proportion of cases and controls with any deletion in the -globin288 296 (51.4) 280 (48.6) 576
similar (2 = 0.57, p = 0.499).
The median (IQR) age of the cases was 25.6 (14.0—41.1)
onths and 147 (51.0%) were males. The majority, 276
95.8%), presented with fever and 104 (36.1%) reported pre-
ious episodes of seizures. Malaria was the leading primary
iagnosis associated with acute seizures and was seen in
86 (64.6%) cases. Other primary diagnoses included respi-
atory tract infections, otitis media, acute diarrhoea, skin
nfections or childhood viral fevers in 79 (27.4%), acute bac-
erial meningitis/septicaemia in 7 (2.4%) and suspected viral
eningo-encephalitis in 7 (2.4%).
aptoglobin genotype, -thalassaemia and acute
eizures
he haptoglobin gene polymorphisms and -globin gene
eletions were in Hardy—Weinberg equilibrium. We found no
igniﬁcant association between acute seizures and the hap-
oglobin HP2-2 genotype (Table 1) or between acute seizures
nd deletions in the -globin gene (Table 2).
Seizures in children with malaria often exhibit complex
eatures (focal, prolonged or repeated) (Idro et al., 2007,
008). We therefore examined this subgroup separately
nd observed no associations between the HP2-2 polymor-
hism or deletions in the -globin gene with malaria-related
eizures. In addition, there was no association between this
olymorphism or deletions and simple febrile seizures in a
roup of 79 children whose seizures were associated with
espiratory tract and ear infections, acute diarrhoea or skin
nfections. The proportions of the HP2-2 genotypes in this
roup of 79 children were: HP1-1 −26.6%, HP1-2 −50.6%
nd HP2-2 −22.8%; (2 for linear trend compared to the
ontrol population 0.011, p = 0.915) and that for deletions
n the -globin gene were: no deletion −28.1%, heterozy-
ous deletion −46.9% and homozygous deletion −25.0% (2
or linear trend compared with the control population 1.265,
= 0.261).
A parental description of the seizure event was available
n 278/288 cases; seizures did not occur in the presence
f the consenting parent in 10 cases. Two hundred and
n





267 308 (57.7) 226 (42.3) 534
267 314 (58.4) 222 (41.6) 534

















































dPolymorphisms and acute seizures in children
thirty four children (84.2%) had generalized seizures, 37
(13.3%) had focal seizures while 7 (2.5%) had secondarily
generalized seizures. HP2-2 genotype and deletions in the -
globin gene were not associated with any particular seizure
manifestation (focal, generalized or focal with secondary
generalization), number of seizures, presentation with sta-
tus epilepticus or with impairment of consciousness.
Discussion
Increasingly, genetic factors are being recognised as impor-
tant risk factors for both acute (febrile seizures, reviewed in
(Audenaert et al., 2006)) and chronic (epilepsies, reviewed
in (Berkovic et al., 2006)) seizure disorders. Studies have
demonstrated an association between the haptoglobin
HP2-2 polymorphism and idiopathic generalized epilepsies
(Saccucci et al., 2004; Sadrzadeh et al., 2004). In this study
we investigated whether this risk extends to acute seizures
and whether another common genetic trait in Africa — a
3.7-kDa deletion in the -globin gene — is associated with
the high incidence of acute seizures in this region. The ﬁnd-
ings do not support our hypothesis: the prevalence of the
HP2-2 genotype and -thalassaemia genotypes were similar
in cases and controls; the median number of seizures dur-
ing the current illness and the frequency of past seizures in
children with these polymorphisms/deletions were similar
to that in cases without.
Accumulation of iron and iron containing products such
as haemoglobin in the interstitial tissues of the brain
can initiate and enhance the generation of reactive oxy-
gen species and cause neuronal damage by peroxidation
of cell membrane lipids (Panter et al., 1985; Suzer et
al., 2000). Haptoglobin is an acute phase protein, which
binds free haemoglobin released into circulation following
haemolysis. Experimental evidence suggests that hypo-
haptoglobinaemia is associated with poor clearance of free
haemoglobin from the central nervous system and may
lead to seizure disorders (Panter et al., 1985). It is pos-
tulated that the inefﬁcient clearance of free haemoglobin
in patients with HP2-2 genotype increases unbound free
haemoglobin in the brain (and other tissues) and may be
associated with increased haemoglobin mediated oxidant
stress on cell membranes, oxidative neuronal damage and
an increased risk of seizures. Deletions in the -globin gene
may affect a child’s susceptibility to acute seizures due to
possible changes in neurotransmitter metabolism. Our study,
which is based on an even larger number of subjects than
previous studies in people with epilepsy suggests that, unlike
the idiopathic generalized epilepsies in which the HP2-2
genotype may be one of many contributory genes involved in
the polygenic inheritance of the seizure disorder (Saccucci
et al., 2004; Sadrzadeh et al., 2004), this polymorphism is
not a risk factor for acute seizure disorders. This result is
consistent for febrile seizures with both simple and com-
plex characteristics. Although we did not measure plasma
haptoglobin levels to directly correlate genotype with phe-
notype, the evidence for the lack of association between
HP2-2 genotype and acute seizures is compelling. It may be
possible that there is a time lag between the onset of free
haemoglobin induced ‘‘oxidative neuronal damage’’ and






ively, repeated episodes of ‘‘neuronal oxidative damage’’
re necessary before the seizure disorder can develop.
Despite this ﬁnding, family studies in children from this
ommunity do provide strong evidence to support a genetic
isk factor for acute seizures (Versteeg et al., 2003). It is
ikely that there are other susceptibility genes. Mutations
nd single nucleotide polymorphisms in voltage and ligand
ated channels such as those described in children with
ebrile seizures or generalized epilepsy with febrile seizures
lus may be possible candidates (Scheffer and Berkovic,
997; Baulac et al., 2001; Ito et al., 2002; Wallace et al.,
002). Screening for these genetic disorders may be a useful
tep.
In the study, clinical assessment was used to deﬁne
eizure type without any EEG data limiting the accuracy
f seizure categorization. Bias could have been introduced
y only including hospitalized patients (probably a more
everely ill group) and selecting controls from a birth cohort
orn in the same hospital. In addition, our sample size was
ased on a relatively large OR of 2.0 at 90% power and 5%
evel of signiﬁcance. At 80% power and the same level of
igniﬁcance, the sample we recruited could detect a signif-
cant result with an OR of 1.8. Other limitations include the
imited power for subgroup analysis. These limitations could
ave biased the results toward the null hypothesis.
In conclusion, the haptoglobin HP2-2 genotype and dele-
ions in the -globin gene are not risk factors for acute
eizures in Kenyan children with and without falciparum
alaria infection. Future studies should examine other sus-
eptibility genes.
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